Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted patentUS 10329298
Inhibitors of cellular metabolic processes
granted patentUS 10329283
G protein-coupled receptor kinase inhibitors and methods for use of the same
granted patentUS 10329260
Human plasma kallikrein inhibitors
granted patentUS 10316371
Screening methods for identifying specific Staphylococcus aureus inhibitors
granted patentUS 10316038
Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
granted patentUS 10315984
Neprilysin inhibitors
granted patentUS 10314908
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted patentUS 10308658
Salt of EGFR inhibitor, crystalline form and uses thereof
granted patentUS 10308656
Small molecule inhibitors of Ku70/80 and uses thereof
granted patentUS 10308646
Pyrimidine compound as JAK kinase inhibitor
granted patentUS 10308608
Histone deacetylase inhibitors
granted patentUS 10308605
Proton pump inhibitors
granted patentUS 10307423
FBXO3 inhibitors
granted patentUS 10307407
9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors
granted patentUS 10301323
Histone deacetylase inhibitors
granted patentUS 10301317
Inhibitors of ERK and methods of use
granted patentUS 10301304
Selective inhibitor of phosphatidylinositol 3-kinase-gamma
granted patentUS 10300107
Compositions and methods for CaMKII inhibitors and uses thereof
granted patentUS 10300074
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
granted patentUS 10300073
Use of CDK9 and BRD4 inhibitors to inhibit inflammation
granted patentUS 10293022
Peptide inhibitors of serotonin 5-HT2C receptor:PTEN interaction
granted patentUS 10292979
Methods of treating cancer patients with farnesyltransferase inhibitors
granted patentUS 10287295
TGF-Ξ² inhibitors
granted